| Literature DB >> 35737898 |
Rose Weeks1,2, Lyra Cooper1, Pooja Sangha1, João Sedoc3,4, Sydney White1, Assaf Toledo5, Shai Gretz5, Dan Lahav5, Nina Martin6, Alexandra Michel1, Jae Hyoung Lee1, Noam Slonim5, Naor Bar-Zeev1.
Abstract
BACKGROUND: Automated conversational agents, or chatbots, have a role in reinforcing evidence-based guidance delivered through other media and offer an accessible, individually tailored channel for public engagement. In early-to-mid 2021, young adults and minority populations disproportionately affected by COVID-19 in the United States were more likely to be hesitant toward COVID-19 vaccines, citing concerns regarding vaccine safety and effectiveness. Successful chatbot communication requires purposive understanding of user needs.Entities:
Keywords: AI; COVID-19; artificial intelligence; chatbots; conversational agent; digital health; health communication; infodemic; infodemiology; misinformation; natural language processing; online health information; public health; social media; user need; vaccination; vaccine communication; vaccine hesitancy
Mesh:
Substances:
Year: 2022 PMID: 35737898 PMCID: PMC9301547 DOI: 10.2196/38418
Source DB: PubMed Journal: J Med Internet Res ISSN: 1438-8871 Impact factor: 7.076
Sample questions and tested response styles.
| Question or comment, | Response | |
|
| ||
|
| Factual-only response | All vaccines go through clinical trials to test safety and effectiveness. For the COVID-19 vaccines, the FDAa set up rigorous standards for vaccine developers to meet and thousands of people worldwide participated in clinical trials before the vaccines became available to the public! |
|
| Empathy-factual response | This is an important question for many people! Once a vaccine is authorized for use, monitoring continues with systems in place to track problems or side-effects that were not detected during clinical trials. You can feel safe knowing these systems have got your back! |
|
| Principled response | It’s very natural to have concerns. Yet, if some people choose to wait, we will not beat this pandemic any time soon. If you are willing to get vaccinated, you can do so knowing that millions have been safely vaccinated and you are helping our path to normalcy. |
|
| ||
|
| Rational argument | The likelihood of experiencing a severe side-effect is very small—less than 5 out of 1,000 people! You’ll probably just have some manageable side-effects that resolve in a few days. |
|
| ||
|
| Testimonial | A Harvard physician said, “while the vast majority of young adults who get COVID-19 are not going to require hospitalization, those who do have a really high risk for adverse outcomes.” A vaccine can prevent severe illness, even if you’re young and healthy. |
|
| ||
|
| Humorous response | Spoiler: People who have COVID-19 should still get vaccinated, but only AFTER you get well! |
aFDA: U.S. Food and Drug Administration.
Participant demographics.
| Characteristic | Participant | |
|
| ||
|
| Female | 16 (80) |
|
| Male | 4 (20) |
|
| ||
|
| High school graduate | 4 (20) |
|
| Some college, no degree | 3 (15) |
|
| Bachelor’s degree or higher | 13 (65) |
|
| ||
|
| American Indian or Alaska Native | 1 (5) |
|
| Asian or Pacific Islander | 4 (20) |
|
| Black or African American | 5 (25) |
|
| Hispanic or Latino | 3 (15) |
|
| White | 4 (20) |
|
| More than 1 race or ethnicity | 3 (15) |
|
| ||
|
| 18-29 | 15 (75) |
|
| 30-49 | 3 (15) |
|
| 50-69 | 2 (10) |
| Self-reported annual household income (2021; US $; n=19), median (range) | 56,000 (25,000-200,000) | |
| Vaccinated (N=20), n (%) | 18 (90) | |
Figure 1Message attributes supporting and hindering credibility with young focus group participants. Textual excerpts coded with both directness- and rapport-related variables (eg, each cell shows a textual passage double coded with a directness-related variable and rapport-related variable). P: participant.